- Male or female patients,
- Aged > than equal to 18 years,
- Patient presenting with an OHT or OAG with an IOP � 21 mmHg,
- Patient currently treated with ophthalmic beta-blockers monotherapy and requiring a
change of the ophthalmic medication due to insufficient response to treatment,
- Patient currently treated by or having received within the last month any ophthalmic
hypotensive agent other than a beta-blocker,
- Patient presenting any contraindication to latanoprost or timolol,
- Patient with history of asthma, obstructive broncho-pneumopathy, sinusal bradycardia
(pulse rate
disease or any other condition that would preclude the patient from taking the
prescribed medication,
- Patient with known intolerance to benzalkonium chloride or any excipient contained in
the trial treatment,